Filter posts

ICYMI: “Deadliest Enemy, Our War Against Killer Germs” Interview

While the biotech industry has provided tremendous support in battling infectious diseases, there is still much …

In New Role, Former UK Prime Minister David Cameron Charts Path ‘Out of Forest’ for Alzheimer's...

Former British Prime Minister David Cameron told attendees at the 2017 BIO International Convention in …

Green Light for CAR-T Leukemia Treatment Is an Historic Moment for Biotechnology

I’ve been President and CEO of BIO for more than a dozen years, and I’ve been …

ICYMI: BIO’s Jim Greenwood Outlines Safety Risks of Drug Importation

“Safe prescription drugs.” That’s what pundits and politicians almost always promise when it comes to …

The Dangers of Drug Importation

The United States is the leader in biopharmaceutical innovation and in guaranteeing that our prescription …

ICYMI: Takeda’s Rajeev Venkayya on Why Vaccines are a Worthy Investment

Although routine vaccinations have seen great success, there is a new challenge ahead. The future …

Sticking to the Facts on Drug Pricing

Former President John Adams is known to have once said, “Facts are stubborn things,” and …

Patients Battle with Insurers for Prescription Drug Coverage

Patients with a difficult or rare disease are no strangers to adversity. There is the …

“Genomics and Personalized Medicine Empower People to Save Their Own Lives”

Wednesday morning of the 2017 BIO International Convention commenced the Personalized Medicine & Diagnostics Track …

BIO Expands Cooperation with China-Based Pharma Group

Earlier this week BIO signed of a Memorandum of Understanding for Cooperation with the Pharmaceutical Association …